APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microbial Source Hydrocolloids

Compare research editions
View pricing & licenses

Selected research

Industry Research

Microbial Source Hydrocolloids Industry Research Report 2026

13 August 2026132 pages

Choose your research edition.

Industry ResearchMicrobial Source Hydrocolloids Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Microbial Source Hydrocolloids Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Microbial Source Hydrocolloids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microbial Source Hydrocolloids Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Microbial Source Hydrocolloids Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Microbial Source Hydrocolloids market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Microbial Source Hydrocolloids is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Microbial Source Hydrocolloids is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Microbial Source Hydrocolloids is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Microbial Source Hydrocolloids include CEAMSA, Hispanagar SA, CP Kelco, DuPont, Cargill, Ingredion, Archer Daniels Midland, Koninklijke DSM and Ashland, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Microbial Source Hydrocolloids market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Microbial Source Hydrocolloids Market by Company

CEAMSA

Hispanagar SA

CP Kelco

DuPont

Cargill

Ingredion

Archer Daniels Midland

Koninklijke DSM

Ashland

Fuerst Day Lawson

Nestle

Jungbunzlauer

Deosen Biochemical

Tate & Lyle

Lubrizol

Fiberstar

B&V SRL

Hawkins Watts

Microbial Source Hydrocolloids Segment by Type

Xanthan Gum

Curdlan

Gellan Gum

Others

Microbial Source Hydrocolloids Segment by Application

Bakery and Confectionery

Dairy

Beverages

Meat & Poultry

Others

Microbial Source Hydrocolloids Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbial Source Hydrocolloids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microbial Source Hydrocolloids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbial Source Hydrocolloids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Microbial Source Hydrocolloids manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Microbial Source Hydrocolloids by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Microbial Source Hydrocolloids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Microbial Source Hydrocolloids Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Microbial Source Hydrocolloids Sales (k units) of Manufacturers (2021-2026) Table 7. Global Microbial Source Hydrocolloids Sales Market Share by Manufacturers (2021-2026) Table 8. Global Microbial Source Hydrocolloids Revenue of Manufacturers (2021-2026) Table 9. Global Microbial Source Hydrocolloids Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Microbial Source Hydrocolloids Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Microbial Source Hydrocolloids Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Microbial Source Hydrocolloids, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Microbial Source Hydrocolloids, Product Type & Application Table 14. Global Microbial Source Hydrocolloids Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Microbial Source Hydrocolloids by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. CEAMSA Company Information Table 19. CEAMSA Business Overview Table 20. CEAMSA Microbial Source Hydrocolloids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. CEAMSA Microbial Source Hydrocolloids Product Portfolio Table 22. CEAMSA Recent Developments Table 23. Hispanagar SA Company Information Table 24. Hispanagar SA Business Overview Table 25. Hispanagar SA Microbial Source Hydrocolloids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Hispanagar SA Microbial Source Hydrocolloids Product Portfolio Table 27. Hispanagar SA Recent Developments Table 28. CP Kelco Company Information Table 29. CP Kelco Business Overview Table 30. CP Kelco Microbial Source Hydrocolloids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. CP Kelco Microbial Source Hydrocolloids Product Portfolio Table 32. CP Kelco Recent Developments Table 33. DuPont Company Information Table 34. DuPont Business Overview Table 35. DuPont Microbial Source Hydrocolloids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. DuPont Microbial Source Hydrocolloids Product Portfolio Table 37. DuPont Recent Developments Table 38. Cargill Company Information Table 39. Cargill Business Overview Table 40. Cargill Microbial Source Hydrocolloids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Cargill Microbial Source Hydrocolloids Product Portfolio Table 42. Cargill Recent Developments Table 43. Ingredion Company Information Table 44. Ingredion Business Overview Table 45. Ingredion Microbial Source Hydrocolloids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Ingredion Microbial Source Hydrocolloids Product Portfolio Table 47. Ingredion Recent Developments Table 48. Archer Daniels Midland Company Information Table 49. Archer Daniels Midland Business Overview Table 50. Archer Daniels Midland Microbial Source Hydrocolloids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Archer Daniels Midland Microbial Source Hydrocolloids Product Portfolio Table 52. Archer Daniels Midland Recent Developments Table 53. Koninklijke DSM Company Information Table 54. Koninklijke DSM Business Overview Table 55. Koninklijke DSM Microbial Source Hydrocolloids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Koninklijke DSM Microbial Source Hydrocolloids Product Portfolio Table 57. Koninklijke DSM Recent Developments Table 58. Ashland Company Information Table 59. Ashland Business Overview Table 60. Ashland Microbial Source Hydrocolloids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Ashland Microbial Source Hydrocolloids Product Portfolio Table 62. Ashland Recent Developments Table 63. Fuerst Day Lawson Company Information Table 64. Fuerst Day Lawson Business Overview Table 65. Fuerst Day Lawson Microbial Source Hydrocolloids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Fuerst Day Lawson Microbial Source Hydrocolloids Product Portfolio Table 67. Fuerst Day Lawson Recent Developments Table 68. Nestle Company Information Table 69. Nestle Business Overview Table 70. Nestle Microbial Source Hydrocolloids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Nestle Microbial Source Hydrocolloids Product Portfolio Table 72. Nestle Recent Developments Table 73. Jungbunzlauer Company Information Table 74. Jungbunzlauer Business Overview Table 75. Jungbunzlauer Microbial Source Hydrocolloids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Jungbunzlauer Microbial Source Hydrocolloids Product Portfolio Table 77. Jungbunzlauer Recent Developments Table 78. Deosen Biochemical Company Information Table 79. Deosen Biochemical Business Overview Table 80. Deosen Biochemical Microbial Source Hydrocolloids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Deosen Biochemical Microbial Source Hydrocolloids Product Portfolio Table 82. Deosen Biochemical Recent Developments Table 83. Tate & Lyle Company Information Table 84. Tate & Lyle Business Overview Table 85. Tate & Lyle Microbial Source Hydrocolloids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Tate & Lyle Microbial Source Hydrocolloids Product Portfolio Table 87. Tate & Lyle Recent Developments Table 88. Lubrizol Company Information Table 89. Lubrizol Business Overview Table 90. Lubrizol Microbial Source Hydrocolloids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Lubrizol Microbial Source Hydrocolloids Product Portfolio Table 92. Lubrizol Recent Developments Table 93. Fiberstar Company Information Table 94. Fiberstar Business Overview Table 95. Fiberstar Microbial Source Hydrocolloids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Fiberstar Microbial Source Hydrocolloids Product Portfolio Table 97. Fiberstar Recent Developments Table 98. B&V SRL Company Information Table 99. B&V SRL Business Overview Table 100. B&V SRL Microbial Source Hydrocolloids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. B&V SRL Microbial Source Hydrocolloids Product Portfolio Table 102. B&V SRL Recent Developments Table 103. Hawkins Watts Company Information Table 104. Hawkins Watts Business Overview Table 105. Hawkins Watts Microbial Source Hydrocolloids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Hawkins Watts Microbial Source Hydrocolloids Product Portfolio Table 107. Hawkins Watts Recent Developments Table 108. Global Microbial Source Hydrocolloids Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Microbial Source Hydrocolloids Sales by Region (2021-2026) & (k units) Table 110. Global Microbial Source Hydrocolloids Sales Market Share by Region (2021-2026) Table 111. Global Microbial Source Hydrocolloids Sales by Region (2027-2032) & (k units) Table 112. Global Microbial Source Hydrocolloids Sales Market Share by Region (2027-2032) Table 113. Global Microbial Source Hydrocolloids Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Microbial Source Hydrocolloids Revenue Market Share by Region (2021-2026) Table 115. Global Microbial Source Hydrocolloids Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Microbial Source Hydrocolloids Revenue Market Share by Region (2027-2032) Table 117. North America Microbial Source Hydrocolloids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Microbial Source Hydrocolloids Sales by Country (2021-2026) & (k units) Table 119. North America Microbial Source Hydrocolloids Sales by Country (2027-2032) & (k units) Table 120. North America Microbial Source Hydrocolloids Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Microbial Source Hydrocolloids Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Microbial Source Hydrocolloids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Microbial Source Hydrocolloids Sales by Country (2021-2026) & (k units) Table 124. Europe Microbial Source Hydrocolloids Sales by Country (2027-2032) & (k units) Table 125. Europe Microbial Source Hydrocolloids Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Microbial Source Hydrocolloids Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Microbial Source Hydrocolloids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Microbial Source Hydrocolloids Sales by Country (2021-2026) & (k units) Table 129. Asia Pacific Microbial Source Hydrocolloids Sales by Country (2027-2032) & (k units) Table 130. Asia Pacific Microbial Source Hydrocolloids Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Microbial Source Hydrocolloids Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Microbial Source Hydrocolloids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Microbial Source Hydrocolloids Sales by Country (2021-2026) & (k units) Table 134. South America Microbial Source Hydrocolloids Sales by Country (2027-2032) & (k units) Table 135. South America Microbial Source Hydrocolloids Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Microbial Source Hydrocolloids Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Microbial Source Hydrocolloids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Microbial Source Hydrocolloids Sales by Country (2021-2026) & (k units) Table 139. Middle East and Africa Microbial Source Hydrocolloids Sales by Country (2027-2032) & (k units) Table 140. Middle East and Africa Microbial Source Hydrocolloids Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Microbial Source Hydrocolloids Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Microbial Source Hydrocolloids Sales by Type (2021-2026) & (k units) Table 143. Global Microbial Source Hydrocolloids Sales by Type (2027-2032) & (k units) Table 144. Global Microbial Source Hydrocolloids Sales Market Share by Type (2021-2026) Table 145. Global Microbial Source Hydrocolloids Sales Market Share by Type (2027-2032) Table 146. Global Microbial Source Hydrocolloids Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Microbial Source Hydrocolloids Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Microbial Source Hydrocolloids Revenue Market Share by Type (2021-2026) Table 149. Global Microbial Source Hydrocolloids Revenue Market Share by Type (2027-2032) Table 150. Global Microbial Source Hydrocolloids Price by Type (2021-2026) & (USD/unit) Table 151. Global Microbial Source Hydrocolloids Price by Type (2027-2032) & (USD/unit) Table 152. Global Microbial Source Hydrocolloids Sales by Application (2021-2026) & (k units) Table 153. Global Microbial Source Hydrocolloids Sales by Application (2027-2032) & (k units) Table 154. Global Microbial Source Hydrocolloids Sales Market Share by Application (2021-2026) Table 155. Global Microbial Source Hydrocolloids Sales Market Share by Application (2027-2032) Table 156. Global Microbial Source Hydrocolloids Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Microbial Source Hydrocolloids Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Microbial Source Hydrocolloids Revenue Market Share by Application (2021-2026) Table 159. Global Microbial Source Hydrocolloids Revenue Market Share by Application (2027-2032) Table 160. Global Microbial Source Hydrocolloids Price by Application (2021-2026) & (USD/unit) Table 161. Global Microbial Source Hydrocolloids Price by Application (2027-2032) & (USD/unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Microbial Source Hydrocolloids Distributors List Table 165. Microbial Source Hydrocolloids Customers List Table 166. Microbial Source Hydrocolloids Industry Trends Table 167. Microbial Source Hydrocolloids Industry Drivers Table 168. Microbial Source Hydrocolloids Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Microbial Source Hydrocolloids Product Image Figure 5. Global Microbial Source Hydrocolloids Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Microbial Source Hydrocolloids Market Size (2021-2032) & (US$ Million) Figure 7. Global Microbial Source Hydrocolloids Sales (2021-2032) & (k units) Figure 8. Global Microbial Source Hydrocolloids Average Price (USD/unit) & (2021-2032) Figure 9. Xanthan Gum Product Image Figure 10. Curdlan Product Image Figure 11. Gellan Gum Product Image Figure 12. Others Product Image Figure 13. Bakery and Confectionery Product Image Figure 14. Dairy Product Image Figure 15. Beverages Product Image Figure 16. Meat & Poultry Product Image Figure 17. Others Product Image Figure 18. Global Microbial Source Hydrocolloids Revenue Share by Manufacturers in 2025 Figure 19. Global Manufacturers of Microbial Source Hydrocolloids, Manufacturing Sites & Headquarters Figure 20. Global Top 5 and 10 Microbial Source Hydrocolloids Players Market Share by Revenue in 2025 Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Microbial Source Hydrocolloids Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 23. Global Microbial Source Hydrocolloids Sales by Region in 2025 Figure 24. Global Microbial Source Hydrocolloids Revenue by Region in 2025 Figure 25. North America Microbial Source Hydrocolloids Market Size by Country in 2025 Figure 26. North America Microbial Source Hydrocolloids Sales Market Share by Country (2021-2032) Figure 27. North America Microbial Source Hydrocolloids Revenue Market Share by Country (2021-2032) Figure 28. United States Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Canada Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Mexico Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Microbial Source Hydrocolloids Market Size by Country in 2025 Figure 32. Europe Microbial Source Hydrocolloids Sales Market Share by Country (2021-2032) Figure 33. Europe Microbial Source Hydrocolloids Revenue Market Share by Country (2021-2032) Figure 34. Germany Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Russia Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Spain Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Netherlands Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Switzerland Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Sweden Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Poland Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Asia Pacific Microbial Source Hydrocolloids Market Size by Country in 2025 Figure 45. Asia Pacific Microbial Source Hydrocolloids Sales Market Share by Country (2021-2032) Figure 46. Asia Pacific Microbial Source Hydrocolloids Revenue Market Share by Country (2021-2032) Figure 47. China Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Japan Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. South Korea Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. India Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Australia Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Taiwan Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. South America Microbial Source Hydrocolloids Market Size by Country in 2025 Figure 56. South America Microbial Source Hydrocolloids Sales Market Share by Country (2021-2032) Figure 57. South America Microbial Source Hydrocolloids Revenue Market Share by Country (2021-2032) Figure 58. Brazil Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Argentina Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Chile Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Middle East and Africa Microbial Source Hydrocolloids Market Size by Country in 2025 Figure 62. Middle East and Africa Microbial Source Hydrocolloids Sales Market Share by Country (2021-2032) Figure 63. Middle East and Africa Microbial Source Hydrocolloids Revenue Market Share by Country (2021-2032) Figure 64. Egypt Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. South Africa Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Israel Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Türkiye Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. GCC Countries Microbial Source Hydrocolloids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Global Microbial Source Hydrocolloids Sales Market Share by Type (2021-2032) Figure 70. Global Microbial Source Hydrocolloids Revenue Market Share by Type (2021-2032) Figure 71. Global Microbial Source Hydrocolloids Price (USD/unit) by Type (2021-2032) Figure 72. Global Microbial Source Hydrocolloids Sales Market Share by Application (2021-2032) Figure 73. Global Microbial Source Hydrocolloids Revenue Market Share by Application (2021-2032) Figure 74. Global Microbial Source Hydrocolloids Price (USD/unit) by Application (2021-2032) Figure 75. Microbial Source Hydrocolloids Value Chain Figure 76. Microbial Source Hydrocolloids Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Microbial Source Hydrocolloids Industry Opportunities and Challenges

Scope & coverage.

Types
  • Xanthan Gum
  • Curdlan
  • Gellan Gum
  • Others
Applications
  • Bakery and Confectionery
  • Dairy
  • Beverages
  • Meat & Poultry
  • Others
Companies covered
  • CEAMSA
  • Hispanagar SA
  • CP Kelco
  • DuPont
  • Cargill
  • Ingredion
  • Archer Daniels Midland
  • Koninklijke DSM
  • Ashland
  • Fuerst Day Lawson
  • Nestle
  • Jungbunzlauer
  • Deosen Biochemical
  • Tate & Lyle
  • Lubrizol
  • Fiberstar
  • B&V SRL
  • Hawkins Watts

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Microbial Source Hydrocolloids Market Size (2021-2032)
  4. 2.2.2 Global Microbial Source Hydrocolloids Sales (2021-2032)
  5. 2.2.3 Global Microbial Source Hydrocolloids Market Average Price (2021-2032)
  6. 2.3 Microbial Source Hydrocolloids by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Xanthan Gum
  9. 2.3.3 Curdlan
  10. 2.3.4 Gellan Gum
  11. 2.3.5 Others
  12. 2.4 Microbial Source Hydrocolloids by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Bakery and Confectionery
  15. 2.4.3 Dairy
  16. 2.4.4 Beverages
  17. 2.4.5 Meat & Poultry
  18. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Microbial Source Hydrocolloids Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Microbial Source Hydrocolloids Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Microbial Source Hydrocolloids Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Microbial Source Hydrocolloids Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Microbial Source Hydrocolloids Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Microbial Source Hydrocolloids, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Microbial Source Hydrocolloids, Product Type & Application
  8. 3.8 Global Manufacturers of Microbial Source Hydrocolloids, Established Date
  9. 3.9 Global Microbial Source Hydrocolloids Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 CEAMSA
  2. 4.1.1 CEAMSA Company Information
  3. 4.1.2 CEAMSA Business Overview
  4. 4.1.3 CEAMSA Microbial Source Hydrocolloids Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 CEAMSA Microbial Source Hydrocolloids Product Portfolio
  6. 4.1.5 CEAMSA Recent Developments
  7. 4.2 Hispanagar SA
  8. 4.2.1 Hispanagar SA Company Information
  9. 4.2.2 Hispanagar SA Business Overview
  10. 4.2.3 Hispanagar SA Microbial Source Hydrocolloids Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Hispanagar SA Microbial Source Hydrocolloids Product Portfolio
  12. 4.2.5 Hispanagar SA Recent Developments
  13. 4.3 CP Kelco
  14. 4.3.1 CP Kelco Company Information
  15. 4.3.2 CP Kelco Business Overview
  16. 4.3.3 CP Kelco Microbial Source Hydrocolloids Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 CP Kelco Microbial Source Hydrocolloids Product Portfolio
  18. 4.3.5 CP Kelco Recent Developments
  19. 4.4 DuPont
  20. 4.4.1 DuPont Company Information
  21. 4.4.2 DuPont Business Overview
  22. 4.4.3 DuPont Microbial Source Hydrocolloids Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 DuPont Microbial Source Hydrocolloids Product Portfolio
  24. 4.4.5 DuPont Recent Developments
  25. 4.5 Cargill
  26. 4.5.1 Cargill Company Information
  27. 4.5.2 Cargill Business Overview
  28. 4.5.3 Cargill Microbial Source Hydrocolloids Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Cargill Microbial Source Hydrocolloids Product Portfolio
  30. 4.5.5 Cargill Recent Developments
  31. 4.6 Ingredion
  32. 4.6.1 Ingredion Company Information
  33. 4.6.2 Ingredion Business Overview
  34. 4.6.3 Ingredion Microbial Source Hydrocolloids Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Ingredion Microbial Source Hydrocolloids Product Portfolio
  36. 4.6.5 Ingredion Recent Developments
  37. 4.7 Archer Daniels Midland
  38. 4.7.1 Archer Daniels Midland Company Information
  39. 4.7.2 Archer Daniels Midland Business Overview
  40. 4.7.3 Archer Daniels Midland Microbial Source Hydrocolloids Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Archer Daniels Midland Microbial Source Hydrocolloids Product Portfolio
  42. 4.7.5 Archer Daniels Midland Recent Developments
  43. 4.8 Koninklijke DSM
  44. 4.8.1 Koninklijke DSM Company Information
  45. 4.8.2 Koninklijke DSM Business Overview
  46. 4.8.3 Koninklijke DSM Microbial Source Hydrocolloids Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Koninklijke DSM Microbial Source Hydrocolloids Product Portfolio
  48. 4.8.5 Koninklijke DSM Recent Developments
  49. 4.9 Ashland
  50. 4.9.1 Ashland Company Information
  51. 4.9.2 Ashland Business Overview
  52. 4.9.3 Ashland Microbial Source Hydrocolloids Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Ashland Microbial Source Hydrocolloids Product Portfolio
  54. 4.9.5 Ashland Recent Developments
  55. 4.10 Fuerst Day Lawson
  56. 4.10.1 Fuerst Day Lawson Company Information
  57. 4.10.2 Fuerst Day Lawson Business Overview
  58. 4.10.3 Fuerst Day Lawson Microbial Source Hydrocolloids Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Fuerst Day Lawson Microbial Source Hydrocolloids Product Portfolio
  60. 4.10.5 Fuerst Day Lawson Recent Developments
  61. 4.11 Nestle
  62. 4.11.1 Nestle Company Information
  63. 4.11.2 Nestle Business Overview
  64. 4.11.3 Nestle Microbial Source Hydrocolloids Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Nestle Microbial Source Hydrocolloids Product Portfolio
  66. 4.11.5 Nestle Recent Developments
  67. 4.12 Jungbunzlauer
  68. 4.12.1 Jungbunzlauer Company Information
  69. 4.12.2 Jungbunzlauer Business Overview
  70. 4.12.3 Jungbunzlauer Microbial Source Hydrocolloids Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Jungbunzlauer Microbial Source Hydrocolloids Product Portfolio
  72. 4.12.5 Jungbunzlauer Recent Developments
  73. 4.13 Deosen Biochemical
  74. 4.13.1 Deosen Biochemical Company Information
  75. 4.13.2 Deosen Biochemical Business Overview
  76. 4.13.3 Deosen Biochemical Microbial Source Hydrocolloids Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Deosen Biochemical Microbial Source Hydrocolloids Product Portfolio
  78. 4.13.5 Deosen Biochemical Recent Developments
  79. 4.14 Tate & Lyle
  80. 4.14.1 Tate & Lyle Company Information
  81. 4.14.2 Tate & Lyle Business Overview
  82. 4.14.3 Tate & Lyle Microbial Source Hydrocolloids Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Tate & Lyle Microbial Source Hydrocolloids Product Portfolio
  84. 4.14.5 Tate & Lyle Recent Developments
  85. 4.15 Lubrizol
  86. 4.15.1 Lubrizol Company Information
  87. 4.15.2 Lubrizol Business Overview
  88. 4.15.3 Lubrizol Microbial Source Hydrocolloids Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Lubrizol Microbial Source Hydrocolloids Product Portfolio
  90. 4.15.5 Lubrizol Recent Developments
  91. 4.16 Fiberstar
  92. 4.16.1 Fiberstar Company Information
  93. 4.16.2 Fiberstar Business Overview
  94. 4.16.3 Fiberstar Microbial Source Hydrocolloids Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Fiberstar Microbial Source Hydrocolloids Product Portfolio
  96. 4.16.5 Fiberstar Recent Developments
  97. 4.17 B&V SRL
  98. 4.17.1 B&V SRL Company Information
  99. 4.17.2 B&V SRL Business Overview
  100. 4.17.3 B&V SRL Microbial Source Hydrocolloids Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 B&V SRL Microbial Source Hydrocolloids Product Portfolio
  102. 4.17.5 B&V SRL Recent Developments
  103. 4.18 Hawkins Watts
  104. 4.18.1 Hawkins Watts Company Information
  105. 4.18.2 Hawkins Watts Business Overview
  106. 4.18.3 Hawkins Watts Microbial Source Hydrocolloids Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Hawkins Watts Microbial Source Hydrocolloids Product Portfolio
  108. 4.18.5 Hawkins Watts Recent Developments
5 Global Microbial Source Hydrocolloids Market Scenario by Region
  1. 5.1 Global Microbial Source Hydrocolloids Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Microbial Source Hydrocolloids Sales by Region: 2021-2032
  3. 5.2.1 Global Microbial Source Hydrocolloids Sales by Region: 2021-2026
  4. 5.2.2 Global Microbial Source Hydrocolloids Sales by Region: 2027-2032
  5. 5.3 Global Microbial Source Hydrocolloids Revenue by Region: 2021-2032
  6. 5.3.1 Global Microbial Source Hydrocolloids Revenue by Region: 2021-2026
  7. 5.3.2 Global Microbial Source Hydrocolloids Revenue by Region: 2027-2032
  8. 5.4 North America Microbial Source Hydrocolloids Market Facts & Figures by Country
  9. 5.4.1 North America Microbial Source Hydrocolloids Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Microbial Source Hydrocolloids Sales by Country (2021-2032)
  11. 5.4.3 North America Microbial Source Hydrocolloids Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Microbial Source Hydrocolloids Market Facts & Figures by Country
  16. 5.5.1 Europe Microbial Source Hydrocolloids Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Microbial Source Hydrocolloids Sales by Country (2021-2032)
  18. 5.5.3 Europe Microbial Source Hydrocolloids Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Microbial Source Hydrocolloids Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Microbial Source Hydrocolloids Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Microbial Source Hydrocolloids Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Microbial Source Hydrocolloids Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Microbial Source Hydrocolloids Market Facts & Figures by Country
  41. 5.7.1 South America Microbial Source Hydrocolloids Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Microbial Source Hydrocolloids Sales by Country (2021-2032)
  43. 5.7.3 South America Microbial Source Hydrocolloids Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Microbial Source Hydrocolloids Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Microbial Source Hydrocolloids Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Microbial Source Hydrocolloids Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Microbial Source Hydrocolloids Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Microbial Source Hydrocolloids Sales by Type (2021-2032)
  2. 6.1.1 Global Microbial Source Hydrocolloids Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Microbial Source Hydrocolloids Sales Market Share by Type (2021-2032)
  4. 6.2 Global Microbial Source Hydrocolloids Revenue by Type (2021-2032)
  5. 6.2.1 Global Microbial Source Hydrocolloids Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Microbial Source Hydrocolloids Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Microbial Source Hydrocolloids Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Microbial Source Hydrocolloids Sales by Application (2021-2032)
  2. 7.1.1 Global Microbial Source Hydrocolloids Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Microbial Source Hydrocolloids Sales Market Share by Application (2021-2032)
  4. 7.2 Global Microbial Source Hydrocolloids Revenue by Application (2021-2032)
  5. 7.2.1 Global Microbial Source Hydrocolloids Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Microbial Source Hydrocolloids Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Microbial Source Hydrocolloids Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Microbial Source Hydrocolloids Value Chain Analysis
  2. 8.1.1 Microbial Source Hydrocolloids Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Microbial Source Hydrocolloids Production Mode & Process
  5. 8.2 Microbial Source Hydrocolloids Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Microbial Source Hydrocolloids Distributors
  8. 8.2.3 Microbial Source Hydrocolloids Customers
9 Global Microbial Source Hydrocolloids Analyzing Market Dynamics
  1. 9.1 Microbial Source Hydrocolloids Industry Trends
  2. 9.2 Microbial Source Hydrocolloids Industry Drivers
  3. 9.3 Microbial Source Hydrocolloids Industry Opportunities and Challenges
  4. 9.4 Microbial Source Hydrocolloids Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst